Skip to main content

Table 4 Baseline demographics

From: Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study

Demographics

Arm A

Arm B

Arm C

A vs B

A vs C

B vs C

p value

p value

p value

Hips

% Male & Female

31.4/32.4

36.0/31.0

32.6/36.6

0.646

0.827

0.490

Age (yr. ± 1 SD)

59.5 (8.6)

60.5 (6.8)

58.9 (9.2)

0.764

0.939

0.553

BMI (± 1SD)

29 (4.5)

30 (4.6)

29.5 (5.6)

0.507

0.837

0.847

Knees

% Male & Female

27.2/37.5

39.5/28.9

33.3/33.7

0.084

0.397

0.369

Age (yr. ± 1 SD)

63.5 (8.2)

63.3 (8.2)

62.3 (8.0)

0.985

0.694

0.791

BMI (± 1 SD)

30.9 (5.9)

31.2 (5.1)

30.8 (5)

0.954

0.993

0.915

Total cohort

% Male & Female

29.3/35.4

37.7/29.7

32.9/34.9

0.111

0.621

0.263

Age (yr. ± 1 SD)

61.6 (8.6)

62 (7.7)

60.7 (8.7)

0.934

0.687

0.467

BMI (± 1SD)

30 (5.4)

30.6 (4.9)

30.2 (5.3)

0.618

0.960

0.783